Tests the Calibreye System device in people with open-angle glaucoma
Checks the safety and feasibility of a device for adults with glaucoma.
Plain-language title generated from the registry record
Registry title: Feasibility Clinical Evaluation of the Calibreye System
Key facts
- Where
- Chihuahua City and Puebla City, MexicoSee the 2 sites
Where in Mexico
- Centro Oftalmologico de ChihuahuaChihuahua City, MexicoTaking people
- Oftalmología Láser de Puebla S.C.Puebla City, MexicoTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Myra Vision Inc.
- Trial code
- NCT05885022
- Record updated
- 15 December 2025
- Original description
To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.Read full original descriptionShow less
Feasibility Clinical Evaluation of the Calibreye System
To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.
Inclusion: Open angle, pseudoexfoliative or pigmentary glaucoma; IOP at preoperative visit of ≥ 18mmHg and ≤ 45mmHg; Visual field mean deviation score of -3dB or worse; Area of healthy, free and mobile conjunctiva in the target quadrant; Shaffer angle grade ≥ 3 in the target quadrant.
Exclusion: Previous intraocular surgery (with the exception of laser trabeculoplasty or uncomplicated phacoemulsification with IOL occurring > 3 months prior to the preoperative visit); Previous glaucoma shunt/valve in the target quadrant; Clinically significant inflammation or infection in the study eye within 30 days prior to the preoperative visit; History of corneal surgery, corneal opacities or corneal disease; Angle closure glaucoma; Congenital, neovascular or other secondary glaucomas; Active diabetic retinopathy.